{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:42:33Z","timestamp":1790772153990,"version":"4.1.0"},"reference-count":96,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Biochem"],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:p>Urine is recognized as the prime matrix for drug test screening with well-established methods and testing protocols. Its major limitation is with regard to the inconvenience of sample collection and lack of integrity due to adulteration, dilution, drug spiking or sample exchange. The question is whether oral fluid, with its apparent better sample integrity, can replace urine for drug screening. This review examines the sample integrity problems and the advantages and limitations of oral fluid and urine in drug screening programmes. The variety of sample collection devices for oral fluid is shown to be a problem with recovery and detection for some drugs. This is examined in relation to the pharmacokinetics of drug metabolism and excretion in this matrix. Buccal contamination with drugs in oral fluid may also cause problems with interpretation. The clinical advantages of oral fluid analysis compared with urine testing are highlighted. Parent drugs are often found in oral fluid where only their metabolites may be found in urine, for example the benzodiazepines. 6-Monoacetylmorphine, an indicative marker of heroin, has a high prevalence in oral fluid from users of this drug but its detection in urine is limited due to its short half-life. Advances in analytical techniques, particularly chromatography linked to tandem mass spectrometry, are helping to promote oral fluid analysis. However, the lack of concordance studies examining both urine and oral fluid drug levels and kinetics in the clinical setting is of some concern.<\/jats:p>","DOI":"10.1258\/acb.2011.011116","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T20:25:04Z","timestamp":1314908704000},"page":"531-541","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":81,"title":["Screening for drugs of abuse: which matrix, oral fluid or urine?"],"prefix":"10.1177","volume":"48","author":[{"given":"Keith R","family":"Allen","sequence":"first","affiliation":[{"name":"Department of Specialist Laboratory Medicine, Leeds Teaching Hospitals, Britannia House, Morley, Leeds LS27 0DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"key":"bibr-ACB-11-116C1","unstructured":"European roadside testing assessment. See http:\/\/www.rosita.org (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C2","first-page":"499","volume":"55","author":"Gerada C","year":"2005","journal-title":"Br J Gen Pract"},{"key":"bibr-ACB-11-116C3","unstructured":"Office of Public Sector Information. See www.opsi.gov.uk (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C4","unstructured":"Home Office. See www.homeoffice.gov.uk\/documents\/cdlist.html (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C5","doi-asserted-by":"publisher","DOI":"10.1258\/0004563054255632"},{"key":"bibr-ACB-11-116C6","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.074237"},{"key":"bibr-ACB-11-116C7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb18346.x"},{"key":"bibr-ACB-11-116C8","first-page":"147","volume":"27","author":"Drummer OH","year":"2006","journal-title":"Clin Biochem"},{"key":"bibr-ACB-11-116C9","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1384.037"},{"key":"bibr-ACB-11-116C10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","volume":"279","author":"Kamendulis LM","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr-ACB-11-116C11","doi-asserted-by":"publisher","DOI":"10.2174\/157488406775268219"},{"key":"bibr-ACB-11-116C12","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.2.65"},{"key":"bibr-ACB-11-116C13","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.9.1486"},{"key":"bibr-ACB-11-116C14","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/39.3.481"},{"key":"bibr-ACB-11-116C15","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.10.1788"},{"key":"bibr-ACB-11-116C16","first-page":"19698","volume":"69","year":"2004","journal-title":"Federal Register"},{"key":"bibr-ACB-11-116C17","unstructured":"SAMHSA. See http:\/\/www.workplace.samhsa.gov\/DrugTesting\/ (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1995.tb03505.x"},{"key":"bibr-ACB-11-116C19","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.460"},{"key":"bibr-ACB-11-116C20","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.7.1051"},{"key":"bibr-ACB-11-116C21","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.8.708"},{"key":"bibr-ACB-11-116C22","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.474"},{"key":"bibr-ACB-11-116C23","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.2.89"},{"key":"bibr-ACB-11-116C24","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/20.3.195"},{"key":"bibr-ACB-11-116C25","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/25.7.572"},{"key":"bibr-ACB-11-116C26","doi-asserted-by":"publisher","DOI":"10.1309\/FQY06F8XKTQPM149"},{"key":"bibr-ACB-11-116C27","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2005.02.023"},{"key":"bibr-ACB-11-116C28","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2006.03.004"},{"key":"bibr-ACB-11-116C29","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.8.614"},{"key":"bibr-ACB-11-116C30","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.4.274"},{"key":"bibr-ACB-11-116C31","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2005.02.028"},{"key":"bibr-ACB-11-116C32","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.7.536"},{"key":"bibr-ACB-11-116C33","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/17.6.338"},{"key":"bibr-ACB-11-116C34","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2007.04.224"},{"key":"bibr-ACB-11-116C35","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/32.6.393"},{"key":"bibr-ACB-11-116C36","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318198670b"},{"key":"bibr-ACB-11-116C37","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.4.211"},{"key":"bibr-ACB-11-116C38","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2005.12.011"},{"key":"bibr-ACB-11-116C39","doi-asserted-by":"publisher","DOI":"10.2174\/187231208784040979"},{"key":"bibr-ACB-11-116C40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.05.036"},{"key":"bibr-ACB-11-116C41","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/23.6.535"},{"key":"bibr-ACB-11-116C42","first-page":"19697","volume":"69","year":"2004","journal-title":"Federal Register"},{"key":"bibr-ACB-11-116C43","unstructured":"European Laboratory Guidelines for Legally Defensible Workplace Drug Testing\n                      . Version 1.0 2002. See http:\/\/www.aebm.org\/documentos\/drogas.pdf (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C44","unstructured":"United Kingdom Laboratory Guidelines for Legally Defensible Workplace Testing\n                      . Version 1.0. March 2001. See www.wdtforum.org.uk (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C45","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00020"},{"key":"bibr-ACB-11-116C46","unstructured":"MoffatAC, OsseltonMD, WiddopB, eds.\n                      Clarke's Analysis of Drugs and Poisons\n                      . 3rd edn. Bath: Pharmaceutical Press, 2004:896"},{"key":"bibr-ACB-11-116C47","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(04)00629-4"},{"key":"bibr-ACB-11-116C48","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.8.424"},{"key":"bibr-ACB-11-116C49","first-page":"215","volume":"50","author":"Krieger G","year":"1992","journal-title":"Beitrage zur Gerichtlichen Medizin"},{"key":"bibr-ACB-11-116C50","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.2.301"},{"key":"bibr-ACB-11-116C51","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.6.370"},{"key":"bibr-ACB-11-116C52","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.08.020"},{"key":"bibr-ACB-11-116C53","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15415J"},{"key":"bibr-ACB-11-116C54","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/27.7.449"},{"key":"bibr-ACB-11-116C55","first-page":"66","volume":"53","author":"Lafargue P","year":"1995","journal-title":"Ann Pharm Fr"},{"key":"bibr-ACB-11-116C56","doi-asserted-by":"publisher","DOI":"10.2174\/1570160053175018"},{"key":"bibr-ACB-11-116C57","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.5.660"},{"key":"bibr-ACB-11-116C58","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211812.27558.6e"},{"key":"bibr-ACB-11-116C59","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199810000-00019"},{"key":"bibr-ACB-11-116C60","unstructured":"Inchem. See http:\/\/www.inchem.org\/documents\/pims\/pharm\/pim139e.htm (last checked 22 March 2011)"},{"key":"bibr-ACB-11-116C61","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.08.020"},{"key":"bibr-ACB-11-116C62","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.7.458"},{"key":"bibr-ACB-11-116C63","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-100100562"},{"key":"bibr-ACB-11-116C64","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.10.1703"},{"key":"bibr-ACB-11-116C65","doi-asserted-by":"publisher","DOI":"10.1373\/49.1.121"},{"key":"bibr-ACB-11-116C66","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1965.tb07575.x"},{"key":"bibr-ACB-11-116C67","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.7.557"},{"key":"bibr-ACB-11-116C68","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.4.187"},{"key":"bibr-ACB-11-116C69","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/32.8.562"},{"key":"bibr-ACB-11-116C70","first-page":"289","volume":"25","author":"Niedbala RS","year":"2001","journal-title":"J AnalToxicol"},{"key":"bibr-ACB-11-116C71","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.5.288"},{"key":"bibr-ACB-11-116C72","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/28.7.546"},{"key":"bibr-ACB-11-116C73","doi-asserted-by":"publisher","DOI":"10.1046\/j.1359-6357.2003.00588.x"},{"key":"bibr-ACB-11-116C74","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/33.4.204"},{"key":"bibr-ACB-11-116C75","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2007.01.005"},{"key":"bibr-ACB-11-116C76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03312.x"},{"key":"bibr-ACB-11-116C77","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(00)00043-5"},{"key":"bibr-ACB-11-116C78","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.05.002"},{"key":"bibr-ACB-11-116C79","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00001"},{"key":"bibr-ACB-11-116C80","first-page":"421","volume":"13","author":"Ogu CC","year":"2000","journal-title":"BUMC Proc"},{"key":"bibr-ACB-11-116C81","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0314-4"},{"key":"bibr-ACB-11-116C82","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00099-0"},{"key":"bibr-ACB-11-116C83","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.08.001"},{"key":"bibr-ACB-11-116C84","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.8.424"},{"key":"bibr-ACB-11-116C85","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544070-00001"},{"key":"bibr-ACB-11-116C86","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/27.7.464"},{"key":"bibr-ACB-11-116C87","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.4.238"},{"key":"bibr-ACB-11-116C88","unstructured":"Benzodiazepine PK Pathway. See http:\/\/www.pharmgkb.org\/do\/serve?objId=PA165111375&objC1s=Pathway (last checked 22 March 2010)"},{"key":"bibr-ACB-11-116C89","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2009.009172"},{"key":"bibr-ACB-11-116C90","unstructured":"MoffatAC, OsseltonMD, WiddopB, eds. Clarke's Analysis of Drugs and Poisons. 3rd edn. Bath: Pharmaceutical Press, 2004:775\u20136"},{"key":"bibr-ACB-11-116C91","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978246720"},{"key":"bibr-ACB-11-116C92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03252.x"},{"key":"bibr-ACB-11-116C93","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.7.478"},{"key":"bibr-ACB-11-116C94","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.9.596"},{"key":"bibr-ACB-11-116C95","doi-asserted-by":"publisher","DOI":"10.1080\/14659890802581628"},{"key":"bibr-ACB-11-116C96","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.8.561"}],"container-title":["Annals of Clinical Biochemistry: International Journal of Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/acb.2011.011116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1258\/acb.2011.011116","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/acb.2011.011116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:56:33Z","timestamp":1777377393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/acb.2011.011116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1258\/acb.2011.011116"],"URL":"https:\/\/doi.org\/10.1258\/acb.2011.011116","relation":{},"ISSN":["0004-5632","1758-1001"],"issn-type":[{"value":"0004-5632","type":"print"},{"value":"1758-1001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}